MRI-Guided Radiation for Recurrent Prostate Cancer Lymph Nodes
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a precise, single-session radiation treatment guided by MRI scans for prostate cancer that has returned in lymph nodes after initial surgery or radiation. The goal is to destroy cancer in these nodes while minimizing damage to surrounding healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had prostate cancer initially treated with surgery and/or radiation
- Your cancer has returned in lymph nodes (verified by a PET scan), located in the pelvis or abdomen
- Your lymph nodes are 2 cm or smaller in size
- You are in generally good health with life expectancy greater than 6 months
- You have no active inflammatory bowel disease (like Crohn's disease or ulcerative colitis) in the pelvis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
This trial tests a new way of giving high-dose radiation therapy to prostate cancer that has spread to nearby lymph nodes. The radiation is given weekly and uses special imaging to target the tumor precisely, which may help control the cancer while limiting side effects.
This study tests a precise radiation treatment for prostate cancer that uses MRI images to guide the radiation beams. It may be an option for men with higher-risk prostate cancer who can have an MRI and have not had radiation before.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.